OxySure (OXYS) Appoints Regional Sales Managers in Atlanta and Pittsburgh
Frisco, Texas, March 18, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced the appointment of Regional Sales Managers in the cities of Atlanta and Pittsburgh. These appointments follow on the recent announcement by the Company of several key staff appointments, including Regional Sales Managers for Chicago and Phoenix, as well as regulatory, engineering and manufacturing appointments.
“We are pleased with our progress and we remain on track with our staffing and business goals for 2015,” stated Julian T. Ross, CEO of OxySure. “We expect to announce additional staffing updates as well as a corporate update very soon,” Ross added.
Specific details regarding the most recent sales appointments are as follows:
* Thomas Spencer Crane – Territory Manager, Atlanta, GA: Mr. Crane joins OxySure after almost 20 years as a sales and sales management professional in the healthcare industry as well as technology and public safety. Mr. Crane has extensive relationships and experience selling to Fortune 500 accounts as well as to the law enforcement community. He holds a B.A. in Finance from Georgia State University.
At OxySure Mr. Crane will focus on developing and supporting new and existing distribution partnerships and strategic alliances, and developing and supporting sales from large corporate and industrial customers as well as the law enforcement community in Atlanta and surrounding areas in the state of Georgia.
* Joshua K. Graham – Territory Manager, Pittsburgh, PA: Mr. Graham’s significant sales and corporate experience includes companies such as Allergan Medical, Bayer and Konica Minolta. As a top ranked account executive with Konica Minolta he exceeded budget and independently managed the entire sales process including developing marketing strategies, managing key account relationships, preparing bid proposals, and negotiating pricing. Mr. Graham holds both a BBA and an MBA from Waynesburg University where was a quarterback for the varsity football team.
At OxySure Mr. Graham will focus on developing and supporting new and existing distribution partnerships and strategic alliances, and developing and supporting sales from large corporate and industrial customers, as well as colleges and sports/athletic organizations in Pittsburgh and surrounding areas in the state of Pennsylvania.
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
Forward-Looking Statements
Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013.
Investor Contacts:
Renmark Financial Communications, Inc.
Bettina Filippone: bfilippone@renmarkfinancial.com
John Boidman: jboidman@renmarkfinancial.com
Tel.: (416) 644-2020 or (514) 939-3989
Redchip Companies, Inc.
Jon Cunningham: jon@redchip.com
800-733-2447, ext. 107
Tags: